Table 2 Frequencies of MLD in 1766... | American Society of Hematology

Table 2

Frequencies of MLD in 1766 patients correlated with age, cytogenetic risk groups, NPM1/FLT3-ITD mutations, and history of AML

	All patients (n = 1766) MLD (%)	P
Age (≤ 60 vs > 60 years)	28.7 vs 30.4	NS (.4)
Cytogenetic risk group (favorable/intermediate/unfavorable)	13.0/28.3/41.6	< .001
FLT3-ITD^* (negative vs positive)	34.1 vs 24.0	< .001
NPM1^† (wild type vs mutation)	31.5 vs 30.2	NS (.7)
History of AML (de novo vs secondary)	25.2 vs 45.4	< .001

	All patients (n = 1766) MLD (%)	P
Age (≤ 60 vs > 60 years)	28.7 vs 30.4	NS (.4)
Cytogenetic risk group (favorable/intermediate/unfavorable)	13.0/28.3/41.6	< .001
FLT3-ITD^* (negative vs positive)	34.1 vs 24.0	< .001
NPM1^† (wild type vs mutation)	31.5 vs 30.2	NS (.7)
History of AML (de novo vs secondary)	25.2 vs 45.4	< .001

MLD indicates multilineage dysplasia according to WHO classification; NS, not significant.

Data available in 1237 patients.

Data available in 1209 patients.